Promoter holding
64.27%
BI
Biostadt India Limited - Due diligence report
A 360° intelligence report on Biostadt India: trust score, financial health, credit view, compliance, directors, growth and distress signals…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Biostadt India — 360° Intelligence Report
Generated from MCA filings & public records70/100
Trust Score
Moderate
Biostadt India is assessed as Moderate with a Trust Score of 70/100. Biostadt India is an active public limited indian non-government company incorporated in 2003, operating in the Agriculture sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Biostadt India Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
70/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
62/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
75/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
60/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
65/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 60/100 Moderate
- Liabilities ≈ 38% EBITDA - stretched.
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A).
Charges position: 4 open (103.21 cr) · 4 satisfied (90.00 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Standard Chartered Bank | 1 | 48.0 cr |
| Hdfc Bank Limited | 2 | 48.0 cr |
| Citi Bank N.A. | 1 | 48.0 cr |
| Others | 1 | 48.0 cr |
| Kotak Mahindra Bank Limited | 1 | 48.0 cr |
| Barclays Bank Plc | 1 | 48.0 cr |
Compliance Score: 62/100 Moderate
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 4 court forum(s).
- 1 auditor resignation(s) filed - latest: Walker Chandiok & Co LLP on 2016-03-14.
- Delayed payments to MSME suppliers disclosed (26 disclosure(s)).
- 20 active GST registration(s).
Legal cases on record (4)
05
Director Intelligence
Stability score: 55/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| NISHREEN JUZAR KHORAKIWALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| UMME AIMAN JUZER KHORAKIWALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| UMME HAANI JUZAR KHORAKIWALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SATISH RATNAKAR KAMATH | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HUZEFA JUZAR KHORAKIWALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ASHOK KRISHNANAND SHASTRY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| HUZEFA JUZAR KHORAKIWALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| JUZAR SAIFUDDIN KHORAKIWALA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 8 directors on the board.
- ASHOK KRISHNANAND SHASTRY has DIN status "Disqualified by RoC u/s 164(2)".
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2024)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2024 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 1 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Biostadt Philippines Inc. | Subsidiary Company | 74.00% |
| Biostadt Singapore Private Limited | Subsidiary Company | 74.00% |
| Vinhthinh Biostadt Joint Stock Company | Joint Ventures | 74.00% |
Key managerial personnel: NISHREEN JUZAR KHORAKIWALA (Whole-time director) · HUZEFA JUZAR KHORAKIWALA (CEO) · HUZEFA JUZAR KHORAKIWALA (Whole-time director) · JUZAR SAIFUDDIN KHORAKIWALA (Managing Director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 60 · Distress 65
Growth signals & trust indicators
Net margin improved to 1.42.
EPFO headcount growing - hiring signal.
Operating for 23+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Profit declined two years in a row.
4 open charge(s) registered - assets are encumbered.
1 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 18.22 Lakh.
4 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence65/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment65/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 4 open charge(s) of 103.21 cr already registered.
- Compliance gaps should be priced into terms.
Investor view68/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management churn warrants questions.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2025
Last AGM held
Annual general meeting
21 Apr 2025
Charge created
Others - 27.50 cr
08 Apr 2025
Charge satisfied
Citi Bank N.A.
31 Mar 2025
Latest balance sheet
Filed with ROC
03 Oct 2024
Charge created
Hdfc Bank Limited - 70.97 Lakh
20 Apr 2023
Director appointed
HUZEFA JUZAR KHORAKIWALA (CEO)
14 Feb 2022
Director ceased
NISHREEN JUZAR KHORAKIWALA
30 Nov 2021
Director ceased
UMME AIMAN JUZER KHORAKIWALA
29 Nov 2021
Director ceased
EDIL JAL KATRAK
Director ceased
ASHOK KRISHNANAND SHASTRY
Director ceased
HUZEFA JUZAR KHORAKIWALA
01 Apr 2021
Director appointed
UMME AIMAN JUZER KHORAKIWALA (Director)
Director appointed
HUZEFA JUZAR KHORAKIWALA (Whole-time director)
31 Mar 2021
Share transfer (FY 2021)
2145000.00000000 shares to HJK Family Trust
01 Oct 2020
Charge satisfied
Kotak Mahindra Bank Limited
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Net worth is positive.
8 active director(s) / partner(s); review board churn before relying on management continuity.
20 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of A from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
6 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Archroma | U20297MH2013FTC242571 | Mumbai, Maharashtra, India |
| Fourrts Laboratories | U85185TN1979PTC007782 | Chennai- 600 096, Tamil Nadu, India |
| Shreya Life Sciences | U51900MH1991PTC061136 | Mumbai, Maharashtra, India |
| Best Value Chem | U24110GJ1996PTC031318 | Vadodara, Gujarat, India |
| Umedica Laboratories Private Limited | U24231GJ1982PTC141202 | Pardi, Gujarat, India |
| Himedia Laboratories | U85195MH1982PTC028194 | Thane, Maharashtra, India |
| Meyer Organics | U24239MH1981PTC023845 | Thane, Maharashtra, India |
| Medleylab | U24230MH1975PLC018296 | Mumbai, Maharashtra, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Biostadt India before audits and certifications: compliance score 62/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Biostadt India: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 60/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 60/100, margin trends, ownership structure and peer set for Biostadt India - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Biostadt India pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (4 case(s) on record), regulatory flags, charge documents trail and director networks for Biostadt India - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Biostadt India an active company?
Biostadt India has MCA status “Active” with a compliance score of 62/100 (Moderate).
Is Biostadt India financially healthy?
Biostadt India has a Financial Health Score of 75/100 (Low Risk) based on its filed financial statements.
Should I do business with Biostadt India?
Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Biostadt India?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 8 active director(s) are on record.
Does Biostadt India have loans or charges against its assets?
4 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.
Is Biostadt India up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 62/100 (Moderate).
Is it risky to lend to Biostadt India?
Its Credit Risk Score is 60/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
